Hakutulokset - Key, Nigel

Analysis of Tissue Factor Positive Microparticles Tekijä Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Current Treatment of Venous Thromboembolism Tekijä Key, Nigel S., Kasthuri, Raj S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Medical Management of Venous Thromboembolism: What the Interventional Radiologist Needs to Know Tekijä Kasthuri, Raj S., Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

How I treat patients with inherited bleeding disorders who need anticoagulant therapy Tekijä Martin, Karlyn, Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Sickle-Cell Trait: Novel Clinical Significance Tekijä Key, Nigel S., Derebail, Vimal K.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Microparticle Analysis in Disorders of Hemostasis and Thrombosis Tekijä Mooberry, Micah J., Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Pregnancy in Sickle Trait: What we Know and What we Don’t Tekijä Wilson, Samuel, Ellsworth, Patrick, Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Negative Health Implications Of Sickle Cell Trait in High Income Countries: From The Football Field To The Laboratory Tekijä Key, Nigel S., Connes, Philippe, Derebail, Vimal K.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Coagulation Abnormalities of Sickle Cell Disease: Relationship with Clinical Outcomes and the Effect of Disease Modifying Therapies Tekijä Noubouossie, Denis, Key, Nigel S., Ataga, Kenneth I.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis Tekijä Gordeuk, Victor R., Key, Nigel S., Prchal, Josef T.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

4084 Predictors of mortality among non-severe hemophilia A patients in the United States Tekijä Lim, Ming Y, Cheng, Dunlei, Key, Nigel

Hae kokoteksti Hae kokoteksti

Tissue Factor; from Morawitz to Microparticles Tekijä Key, Nigel S., Geng, Jian-Guo, Bach, Ronald R

Hae kokoteksti Hae kokoteksti

Red blood cells and thrombin generation in sickle cell disease Tekijä Whelihan, Matthew F., Lim, Ming Y., Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria Tekijä Lim, Ming Y., Volmar, Keith E., Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues Tekijä Campello, Elena, Ilich, Anton, Simioni, Paolo, Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

How to discuss gene therapy for haemophilia? A patient and physician perspective Tekijä Miesbach, Wolfgang, O’Mahony, Brian, Key, Nigel S., Makris, Mike

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Using heparin molecules to manage COVID‐2019 Tekijä Liu, Jian, Li, Jine, Arnold, Katelyn, Pawlinski, Rafal, Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer Tekijä Kasthuri, Raj S., Hisada, Yohei, Ilich, Anton, Key, Nigel S., Mackman, Nigel

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses Tekijä Mackman, Nigel, Antoniak, Silvio, Wolberg, Alisa S., Kasthuri, Raj, Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Neutrophils: back in the thrombosis spotlight Tekijä Noubouossie, Denis F., Reeves, Brandi N., Strahl, Brian D., Key, Nigel S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti